Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Infection and Immunity

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.61.8.3403-3411.1993PMID 7687586PMCID PMC281016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice

  1993cited by this paper
• Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

  1993influential reference
• Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum

  1992cited by this paper
• A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.

  1992cited by this paper
• Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection

  1992cited by this paper
• Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1.

  1992cited by this paper
• Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum

  1991cited by this paper
• Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients.

  1990cited by this paper
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies

  1990cited by this paper
• Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins.

  1990cited by this paper
• A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii.

  1989cited by this paper
• Plasmodium falciparum: dimorphism of the p190 alleles.

  1989cited by this paper
• The N-terminal amino acid sequences of the Plasmodium falciparum (FCB1) merozoite surface antigens of 42 and 36 kilodalton, both derived from the 185-195-kilodalton precursor.

  1989cited by this paper
• The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody.

  1988cited by this paper
• Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum

  1988cited by this paper
• Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli

  1988cited by this paper
• Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate.

  1988cited by this paper
• Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum.

  1988cited by this paper
• Induction of protective immunity against experimental infection with malaria using synthetic peptides

  1987cited by this paper
• Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro.

  1987cited by this paper
• A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats.

  1987cited by this paper
• Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

  1987cited by this paper
• Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope.

  1987cited by this paper
• Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum.

  1987influential reference
• Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum

  1987cited by this paper
• Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene.

  1986cited by this paper
• Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

  1986cited by this paper
• Antigenic diversity and size diversity of P. falciparum antigens in isolates from Gambian patients. II. the schizont surface glycoprotein of molecular weight approximately 200 000.

  1986cited by this paper
• Antigenic diversity and size diversity of P. falciparum antigens in isolates from Gambian patients. II. The schizont surface glycoprotein of molecular weight ˜ 200 000

  1986cited by this paper
• Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level.

  1985cited by this paper
• Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum

  1985cited by this paper
• The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor

  1984cited by this paper
• Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum.

  1984cited by this paper
• Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages

  1984cited by this paper
• Use of human plasma for continuous in vitro cultivation of Plasmodium falciparum.

  1984cited by this paper
• Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria

  1984cited by this paper
• Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites

  1983cited by this paper
• Synchronization of Plasmodium falciparum erythrocytic stages in culture.

  1979cited by this paper
• Human malaria parasites in continuous culture.

  1976cited by this paper

• Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1–42 Vaccines

  2013cites this paper
• Broadly reactive antibodies specific for Plasmodium falciparum MSP-119 are associated with the protection of naturally exposed children against infection

  2012cites this paper
• IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran.

  2011cites this paper
• Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits.

  2009cites this paper
• Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda.

  2009cites this paper
• Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.

  2007cites this paper
• Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes.

  2007cites this paper
• Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development.

  2007cites this paper
• Utilization of Nucleotide Probes in PCR‐ELISA Procedure for the Quantitative Determination of Plasmodium Falciparum DNA in Malaria

  2007cites this paper
• Identification of a rare point mutation at C-terminus of merozoite surface antigen-1 gene of Plasmodium falciparum in eastern Indian isolates.

  2004cites this paper
• Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1

  2003cites this paper
• In Vivo Expression and Immunological Studies of the 42-Kilodalton Carboxyl-Terminal Processing Fragment of Plasmodium falciparum Merozoite Surface Protein 1 in the Baculovirus-Silkworm System

  2002influential citation
• Vaccin contre la malaria

  2000cites this paper
• Partial Protection against Plasmodium vivaxBlood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer Adjuvant

  1999cites this paper
• Glycosylation and proteolytic processing of 70 kDa C-terminal recombinant polypeptides of Plasmodium falciparum merozoite surface protein 1 expressed in mammalian cells.

  1999cites this paper
• A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

  1998cites this paper
• Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.

  1997cites this paper
• Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys

  1996cites this paper
• Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection

  1996cites this paper
• Influence of adjuvants on murine immune responses against the C‐terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein‐1 (MSP‐1)

  1996cites this paper
• A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria

  1996cites this paper
• Induction of anti-malarial transmission blocking immunity with a recombinant ookinete surface antigen of Plasmodium berghei produced in silkworm larvae using the baculovirus expression vector system.

  1996cites this paper
• Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.

  1996cites this paper
• Human immune responses to the C-terminus of the malaria vaccine candidate antigen, the major merozoite surface protein of Plasmodium falciparum (PfMSP1)

  1995cites this paper
• Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.

  1995cites this paper
• Induction of antibodies to the Plasmodium falciparum merozoite surface protein-1 (MSP1) by cross-priming with heterologous MSP1s.

  1994cites this paper
• Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.

  1994cites this paper
• Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

  1994cites this paper
• High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.

  1994cites this paper